Rheumatoid Arthritis Flashcards
RA Definition
Chronic autoimmune systemic illness
characterised by symmetrical peripheral arthritis
and other systemic features
RA diagnosis needs a score of x according to 2010 EULAR Classification
6 OR MORE out of 10
4 sub-categories of RA Classification/Criteria
In each sub-category, what would score high pointing to a dx of RA?
Joint Involvement (poly + small joints)
Serology (RF +ve, ACPA +ve)
Acute phase reactants (raised)
Duration of symptoms 6w
Epidemiology of RA
Gender
Prevalence
Peak age of onset
But may occur at any age from ____
F:M 3:1
1% of population
4th or 5th decade
But may occur at any age from 16 y
Aetiology RA
Genetic - closest association with specific amino acid sequences at positions ____ of _____
What are the susceptibility genes?
Environmental factors (2)
Genetic - closest association with specific amino acid sequences at positions 70-74 of DRb1
HLA DR1 and HLA DR4
Environmental factors:
Smoking
Chronic infection - peri-odontal disease
Pathogenesis RA
3 stages
Rheumatoid factor binding to IgG forming immune complexes
Not easily cleared
Activate complement - further inflammation
Activation of macrophages
RA Symptoms 4
Pain
Swelling
Loss of function
Systemic symptoms
Symptoms RA
- Systemic symptoms
- Non-specific (3)
Fatigue
Weight loss
Anemia
Which types of malignancy have higher incidence assoc with RA
Leukemia and Lymphoma
RA Clinical Signs (5)
Swelling
Tenderness
Limitation of ROM
- Redness*
- Heat*
Investigations RA (5)
Immunology
- RF
- ACPA or Anti-CCP
X-rays
USS
Raised CRP/ESR
DAS28 score
DAS28 score - how does it relate to RA?
What score represents clinical remission?
What score indicates eligibility for biology therapy
DAS28 score – monitor disease activity (disease activity score)
DAS<2.4 represents clinical remission
DAS>5.1 represents eligibility for biologic therapy
4 modes of management of RA
NSAIDS
DMARDS
Biologics
Corticosteroids
Name 4 DMARDs used in RA
Whats the gold standard DMARD drug
Methotrexate
Sulfasalazine
Hydroxychloroquine
Leflunomide
Name 5 drugs under ‘Biologics’ category of RA MX
TNF-alpha inhibitors Etanercept
IL-1 inhibitors Anakinra
IL-6 inibitors Tocilizumab
Anti-B cell therapy - Rituximab
Anti-T cell therapies - Abatacept
What are the extra-articular manifestations of RA? [4]
Extra-articular
- Rheumatoid nodules
- Increased risk of atherosclerosis
- Interstitial lung fibrosis
- Pleural effusions (SOB)
What is Felty’s syndrome? Why can it be dangerous?
Triad of:
RA
Splenomegaly
Granulocytopenia
Can lead to life-threatening infections
X-ray of RA
Early [3]
Late [3]
soft tissue swelling, juxta-articular osteopenia, loss of joint space
Late changes: bony erosions, subluxation, complete carpal destruction
L – loss of joint space
E – erosions
S – soft tissue swelling
S – soft bones (osteopenia)
What finding would you see on FBC
Increased platelets
DMARDs
Indications for prescribing [1]
How long before patient should expect symptomatic benefit [1]
Best results with? [3]
SE [3]
How to counter this side effect [1]
Should be started within 3 months of persistent symptoms
Can take 6-12w for symptomatic benefit
DMARD monotherapy +/- a short-course of bridging prednisolone (NICE, 2018)
SE: immunosupression, pancytopenia, neutropenic sepsis so regular FBC monitoring
DMARDs side effects
Methotrexate [3]
Sulfasalazine [3]
Leflunomide [4]
Hydroxychloroquine [1]
Methotrexate - pneumonitis, oral ulcers, hepatotoxicity
Sulfasalazine - rash, decreased sperm count, oral ulcers
Leflunomide - teratogenicity, oral ulcers, increased BP, hepatotoxicity
Hydroxychloroquine - Bull’s eye retinopathy
Biologics
First line? When is this indicated? [2]
Second line? [2]
Third line? [2]
- TNF alpha inhibitors - after failure of 2 DMARDs and DAS28>5.1
- Anti B-cell therapy - after failure of DMARDs and TNF alpha inhibitor
- IL6 inhibitior - after failure of TNF alpha and anti-B cell therapy
SE profile of biologics [5]
Serious infection eg reactivation of TB, Hep B
Worsening heart failure
Hypersensitivity
Blood disorders
Reversible SLE-type illness may evolve
Palindromic RA
Presentation of joint inflammation [2]
Episodic and sequential moving from one joint to another
Hours-days then symptom-free periods that last days-months